DEFINITIONS AND IMPACT
Health is defined as the absence of disease with a state of physical, mental and social welfare. 1 Overweight and obesity describe weight ranges that are above the healthy limits, and are frequently assessed by body mass index (BMI) and also by waist circumference (WC) and body fat percentage. 2 BMI provides a rough estimate of the body fat percentage for most people, with few exceptions as in the case of athletes (it overestimates fat mass) and older people (it underestimates fat mass). Central body fat distribution has been regarded as an important predictor of chronic disorders such as cardiovascular diseases and type 2 diabetes. WC is highly correlated with abdominal fat, and is considered a surrogate indicator of central fat mass. 3 WC is a better predictor of the risk of diseases than BMI. 4 However, because of the lack of a uniform protocol for the measurement of WC, 5 it has not been extensively adopted, and BMI is still the most widely used tool for assessing weight status. A BMI between 25 and 29.9 is considered overweight, whereas a BMI over 30 is regarded as obese. 2 Overweight and obesity are two stages that can hinder the normal body actions and increase the risk of several diseases such as cardiovascular disorders, type 2 diabetes, cancer and musculoskeletal disorders. 2 Moreover, obesity has been reported to affect mental health 6 and to interfere with muscle function and strength, possibly leading to impaired physical movement. 7 Risks associated with excess body weight start at the overweight stage, increase with increasing weight, 8 and raise the medical care costs that largely outweigh those of the normal weight population. 1 
THE ADIPOSE TISSUE
It is now agreed that the adipose tissue is no longer recognized as a site merely for fat storage, as traditionally known, but as a secretor of inflammatory factors including adipokines and cytokines, which have a role in atherosclerosis, diabetes mellitus, inflammation, endothelial dysfunction and kidney problems. 9 It is then reasonable that the increase in fat mass will exacerbate or lead to many chronic complications. In fact, overweight and obese individuals (BMI>25) have been reported to have a higher inflammatory state and endothelial oxidative stress than normal weight people, providing an explanation for the link between obesity and atherosclerotic diseases. 10 
OBESITY AS A 'DISEASE'
According to a recent statement of the American association of endocrinologists, obesity has been recognized as a disease, as it fulfils the three disease criteria including: morbidity (for example, risk of diabetes and heart diseases), specific signs and symptoms (for example, low self-esteem and joint pain) and alteration in body functioning (for example, sleep apnea).
11 Therefore, the description of obesity extends from an important risk factor for diseases to a disease by itself, highlighting further discrepancies between the normal weight and obese population. As for the overweight category (BMI between 25 and 29.9), no study or statement has qualified overweight status as a disease. However, the health risks start at the overweight stage and increase with increasing weight, as previously mentioned. The reason behind the fact why overweight people are at risk seems to be directed towards the excess adipose tissue, which by its inflammatory function increases the disease risk. 9 Here, the inaccuracy of BMI remains in its failure to differentiate between individuals with high levels of body fat and those with high levels of physical fitness, as described earlier. However, the latter group obviously represents a minor fraction of the population, and otherwise, overweight is linked to an elevated fat percentage.
The previous statements emphasize the following points: overweight and obesity are correlated with a high risk of diseases and metabolic complications, and obesity has even been regarded as a disease. In fact, the consequences on social, physical and mental statuses make overweight and obese individuals not qualify for the 'World Health Organization' health definition. Nevertheless, the majority of recent studies published in recognized journals are still considering overweight and obese individuals as 'healthy'.
12-14 Moreover, although it was previously suggested that a small group of obese individuals may fall into the category of 'metabolically healthy obese', who show no signs of cardiovascular risk, 15 a recent meta-analysis of eight studies documented that metabolically healthy obese are at a higher risk of diseases than normal weight individuals, even with the absence of metabolic defects. 16 This meta-analysis is to confirm that there is no healthy pattern of an elevated BMI, suggesting the need for a uniformity of description of overweight and obese in all research studies. In fact, the label 'population at risk' might better represent their current health state. It is also worth noting that, with the effort to identify most of the individuals at risk in the population, BMI fails to detect those with 'normal weight obese syndrome', which characterises subjects with a BMI o 25 but with a high fat percentage and therefore with a high disease risk. 17 Consequently, some normal weight high-risk individuals may be falsely regarded as healthy. This raises the need for other measures to identify this population at risk in order to implement appropriate prevention strategies.
In addition, owing to the different molecular and physiological mechanisms between the two BMI categories, overweight and normal weight individuals may respond differently to interventions in clinical trials. Many examples are available in the literature: for instance, regarding dietary interventions, normal weight and overweight individuals showed different responses in insulin sensitivity indices after oral L-carnitine supplementation 18 and polyphenol-rich food supplementation. 19 Differences in the response to serum 25-hydroxyvitamin D concentrations after vitamin D3 supplementation also differed according to BMI. 20 As for musculoskeletal interventions, the overweight group exhibited a higher fatty atrophy of the gluteus medius muscle after a hip endoprosthesis implant compared with the normal weight group. 21 Moreover, obesity has been associated with poor memory performance 22 and a higher risk of cognitive impairment 23 than normal weight, resulting in possible differences in the response to memory and psychological interventions. Consequently, grouping normal weight and overweight under the same category of healthy participants, without considering stratification or adjustment for the potential confounding effect of BMI may lead to the outcomes being inaccurate or even misleading. A problem remains in the reliability of comparison between studies, particularly when drawing conclusions in meta-analysis. Epidemiological studies analysing risk factor-associated diseases should also be precise regarding the definition of the healthy population. As for physiological differences, overweight and obese individuals usually show different baseline levels in several markers such as ferritin levels, 24 TSH (thyroid-stimulating hormone) 25 and vitamin D3 serum levels. 26 This might lead to an imprecise determination of the correlation between risk exposure and health conditions.
In view of the points exposed above, the following facts need to be stated: generally, the idea is not to exclude overweight and obese individuals from research studies, but to acknowledge the difference between the normal weight and overweight categories, and to avoid labelling the latter population with the term 'healthy' in future studies. As BMI does not necessarily affect the outcomes of all studies, [27] [28] [29] stratification based on BMI may lead to more reliable results. It is also important to mention that the exclusion of overweight and obese participants from studies, if considered, is dependent on the research questions. In studies investigating outcomes on the general healthy population, overweight and obese may need to be excluded, whereas this is not the case in studies investigating conditions such as obesity-related diseases.
In conclusion, the discrepancies exposed above drive towards the necessity of differentiating between the two BMI categories. Hence, classifying the overweight and obese population as 'population at risk' in epidemiological studies and clinical trials will provide more accurate results, allow the appropriate comparison between studies and avoid labelling subjects with a wrong designation.
